Effects of Hoe 140, a bradykinin B2-receptor antagonist, on renal function in conscious normotensive rats

P. Madeddu, V. Anania, P. Pinna Parpaglia, M. P. Demontis, M. V. Varoni, G. Pisanu, C. Troffa, G. Tonolo, N. Glorioso

Research output: Contribution to journalArticlepeer-review

Abstract

1. The present study was designed to determine if endogenous kinins are involved in the regulation of arterial blood pressure and renal function in conscious rats given deoxycorticosterone enantate (DOC, 25 mg kg-1, s.c., weekly) or vehicle for two weeks. 2. The bradykinin B2-receptor antagonist, D-Arg[Hyp3,Thi5,D-Tic7,Oic8]-bradykinin (Hoe 140), at a dose of 300 μg kg-1, s.c., blocked the hypotensive effect of 300 ng kg-1 bradykinin i.a., but it did not alter the blood pressure lowering action of 300 ng kg-1 acetylcholine or prostaglandin E2. Inhibition of the response to bradykining persisted up to 6 h after the administration of Hoe 140. 3. Administration of 300 μg kg-1 Hoe 140 s.c. four times a day did not alter mean blood pressure, renal blood flow, or renal function in rats given DOC-vehicle. However, it decreased urinary volume by 70% (from 48.2 ± 3.8 to 14.3 ± 3.7 ml 24 h-1, P <0.01) and urinary secretion of sodium by 54% (from 1.02 ± 0.05 to 0.47 ± 0.16 mmol 24 h-1, P <0.01) and potassium by 30% (from 2.93 ± 0.15 to 2.04 ± 0.15 mmol 24 h-1, P <0.05) in DOC-treated rats. Mean blood pressure, glomerular filtration rate and total renal blood flow remained unchanged. 4. Our results suggest that endogenous kinins play a role in the regulation of renal excretion of water and sodium in the presence of elevated levels of DOC.

Original languageEnglish
Pages (from-to)380-386
Number of pages7
JournalBritish Journal of Pharmacology
Volume106
Issue number2
Publication statusPublished - 1992

Keywords

  • Blood pressure
  • Bradykinin
  • Hoe 140
  • Kallikrein
  • Kinin antagonist
  • Renal blood flow
  • Renal function

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Effects of Hoe 140, a bradykinin B<sub>2</sub>-receptor antagonist, on renal function in conscious normotensive rats'. Together they form a unique fingerprint.

Cite this